HALO – halozyme therapeutics, inc. (US:NASDAQ)

News

Halozyme Therapeutics (HALO) was downgraded by Weiss Ratings from "buy (b-)" to "hold (c)".
Halozyme to Participate in Upcoming Investor Conferences [Yahoo! Finance]
2 Reasons to Like HALO (and 1 Not So Much) [Yahoo! Finance]
Halozyme to Participate in Upcoming Investor Conferences
Why Halozyme Therapeutics (HALO) Is Down 7.9% After Acquisition-Driven Q4 Loss And 2026 Outlook Reaffirmation [Yahoo! Finance]
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com